Evidence map›Paper›PMID 39623926›Full record

ArticleInternational journal of technology assessment in health care2024

Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c.

Chiara Di Resta, Chiara Sacco, Mladen Trbos, Massimo Locatelli, Giuseppe Banfi, Rossella Tomaiuolo

Abstract readComparative Study
In one paragraph

Article in International journal of technology assessment in health care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chiara Di RestaFaculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.ORCID https://orcid.org/0000-0003-2880-6631
Chiara SaccoFaculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Mladen TrbosLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Massimo LocatelliLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Giuseppe BanfiFaculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Rossella TomaiuoloFaculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.ORCID https://orcid.org/0000-0002-2828-782X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn the field of Laboratory Medicine, the evolution of knowledge and the innovation of technologies are the basis of analytical and diagnostic progress, leading to the development of new solutions based on innovative technologies. However, these advances must be accompanied by evidence of appropriateness, diagnostic effectiveness, and organizational efficiency, considering the test's first impact on patient outcomes.

methodsThe Health Technology Assessment (HTA) is a valid management tool to support Laboratory Medicine professionals in assessing technologies and which is the most appropriate to adopt. This study is an illustrative case of the application of HTA, exploiting the EUnetHTA Core Model, on two analyzers able to determine the glycated hemoglobin (Hemoglobin A1c, HbA1c), the Capillarys 2 Flex piercing analyzer and the HLC-723G11 analyzer in the Laboratory Medicine Service of the IRCCS San Raffaele Hospital (Milan, IT). The main focus is related to potential differences in methods, organizational aspects, and clinical effectiveness of these approaches for measuring HbA1c.

resultsThe EUnetHTA Core Model has proven to be the optimal method for HTA in the field of Laboratory Medicine, as it allows to highlight both the peculiarities of the methods on which the analyzers are based and the clinical efficacy of the laboratory test on specific patient populations, considering individual variations in treatment responses, assessing the potential benefits for individual patients or small groups.

conclusionsThis granular analysis helps provide insights into the effectiveness and value of healthcare interventions at the patient level, contributing to evidence-based decision-making in clinical practice and healthcare policy.

Indexed as

Glycated HemoglobinTechnology Assessment, BiomedicalHumansGlycated HemoglobinHb1AcHealth Technology Assessmenthemoglobin variantsinnovation in laboratory medicinelaboratory medicine equipment

Identifiers

PMID39623926
PMCPMC11703618

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.